Loading...
ht001426CAPS
Response Deadline
Jul 2, 2026, 2:00 PM(EDT)14 days
Eligibility
Contract Type
Sources Sought
Defense Health Agency Contracting Activity (DHACA)
Northeastern Market – Contracting Division (NM-CD)
Subj: Source Sought Announcement
This is a sources sought/synopsis announcement issued by the Defense Health Agency (DHA) National Capital Region (NCR) as part of its market research, on behalf of the Walter Reed National Military Medical Clinic (WRNMMC), 8901 Wisconsin Avenue Building 54 Bethesda, MD 20889 and Alexander T. Augusta Military Medical Center (ATAMMC) 9300 DeWitt Loop, Fort Belvoir, VA 22060, in accordance with FAR Part 13.303, Blanket Purchase Agreements (BPAs) and FAR 16.7, Agreements. The Government intends to award a Firm-Fixed Price, for commercial items / services for the procurement of all adult and neonatal Total Parenteral Nutrition (TPN) admixtures; including, but not limited to, TrophAmine +NICU Starter Bag, FreAmine, PlenAmine, HepatAmine, NephrAmine, and FreAmine HBC; as well as amino acids admixtures; including, but not limited to, Clinisol, Travasol, and Aminosyn; 20% Fat Emulsion admixtures and Cariopelgia products; including Microplegia syringes
Currently, CENTRAL ADMIXTURE PHARMACY SERVICES, INC, 6430 Oak Cyn STE 200 Irvine, California, 92618-5234, United States is the products/item or service manufacturer and authorized distributor. The NAICS code is 325412 Pharmaceutical Preparation Manufacturing, with a size standard of 1,300. Federal Supply Class or Product Service Codes such as: 6505, 6515, and 6506 are just a few classes of supplies, others not listed.
This source sought announcement is a request for information ONLY to be used for preliminary market research information and planning purposes only. This notice is not a request for competitive proposals. There will be no Request for Quote or Solicitation available for competitive proposals at the present time. Phone calls will not be accepted. This notice is not a request for competitive quotes; however, the government will consider responses to this notice within fifteen (15) days of this posting. Interested parties, may express their interest and provide a capabilities statement products list NLT 2 July 2026 at 10:00 AM EST. A determination by the government not to compete this requirement based upon responses to this notice is solely within the discretion of the government. Information received as a result of this notice will be considered solely for the purpose of determining whether to conduct a competitive procurement.
Interested Parties:
Please submit non-proprietary information “Only.” The Government will not be responsible for proprietary, or competition sensitive information contained in responses received.
Responses to this announcement will not be returned. Responders are solely responsible for all expenses associated with responding to this announcement. Government will not be financially responsible for information received in response to this announcement. Phone calls will not be accepted.
The points of contact for this action are Claudia Febres Mormontoy, Contracts Specialist Email: claudia.a.febresmormontoy.ctr@health.mil.
DEPT OF DEFENSE
DEFENSE HEALTH AGENCY (DHA)
DEFENSE HEALTH AGENCY
DEFENSE HEALTH AGENCY
HCD NORTHEAST
8111 GATEHOUSE ROAD, 2ND FLOOR
FALLS CHURCH, VA, 22042
NAICS
Pharmaceutical Preparation Manufacturing
PSC
DRUGS AND BIOLOGICALS
Set-Aside
No Set aside used